Robuta

https://dhvi.duke.edu/profile/laura-pope-hale Laura Pope Hale | Duke Human Vaccine Institute human vaccinelaurapopehaleduke https://dhvi.duke.edu/programs-and-centers/shared-resources/cores Cores | Duke Human Vaccine Institute human vaccinecoresdukeinstitute https://dhvi.duke.edu/profile/andrew-neil-macintyre Andrew Neil Macintyre | Duke Human Vaccine Institute andrew neilhuman vaccinemacintyredukeinstitute https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/flowjo-licenses FlowJo Licenses | Duke Human Vaccine Institute human vaccineflowjolicensesdukeinstitute https://dhvi.duke.edu/personnel/marek-poniewierski Marek Poniewierski | Duke Human Vaccine Institute human vaccinemarekdukeinstitute https://dhvi.duke.edu/ Duke Human Vaccine Institute human vaccinedukeinstitute https://dhvi.duke.edu/personnel/darin-weed Darin Weed | Duke Human Vaccine Institute Training B.S., Biotechnology, Minnesota State University Ph.D., Immunology and Infectious Disease, Washington State University Postdoctoral, University of... human vaccinedarinweeddukeinstitute https://dhvi.duke.edu/personnel/georgia-tomaras-phd Georgia Tomaras, PhD | Duke Human Vaccine Institute human vaccinegeorgiaphddukeinstitute https://dhvi.duke.edu/programs-and-centers/chavd/chavd-annual CHAVD Annual Retreats | Duke Human Vaccine Institute annual retreatshuman vaccinedukeinstitute https://dhvi.duke.edu/profile/matthew-kelly Matthew Kelly | Duke Human Vaccine Institute matthew kellyhuman vaccinedukeinstitute https://dhvi.duke.edu/personnel/salvatore-scianna Salvatore Scianna | Duke Human Vaccine Institute Salvatore Scianna has worked on the NIAID/DAIDS Virology Quality Assurance Program for over 25 years. Sal oversees the production, validation, and distribution... human vaccinesalvatoresciannadukeinstitute https://dhvi.duke.edu/programs-and-centers/collaborative-influenza-vaccine-innovation-centers/clinical-core/accessioning Accessioning Unit & Biorepository | Duke Human Vaccine Institute The team provides support for the recruiting participants of all ages as well as processing, human vaccineaccessioningunitbiorepositoryduke https://dhvi.duke.edu/programs-and-centers/immunology-virology-quality-assessment-center/research-programs/virology-2 Virology Quality Assurance Program (VQA) | Duke Human Vaccine Institute quality assurance programhuman vaccinevirologyvqaduke https://dhvi.duke.edu/personnel/darren-morrow Darren Morrow | Duke Human Vaccine Institute human vaccinedarrenmorrowdukeinstitute https://dhvi.duke.edu/cain-lab Cain Lab | Duke Human Vaccine Institute human vaccinecainlabdukeinstitute https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/technical-help Technical Help | Duke Human Vaccine Institute technical helphuman vaccinedukeinstitute https://dhvi.duke.edu/saunders-lab Saunders Lab | Duke Human Vaccine Institute human vaccinesaunderslabdukeinstitute https://dhvi.duke.edu/personnel/monica-johnson Monica Johnson | Duke Human Vaccine Institute human vaccinemonicajohnsondukeinstitute https://dhvi.duke.edu/programs-and-centers/shared-resources/cores/flow-cytometry/policies-and-faqs Policies and FAQs | Duke Human Vaccine Institute policies and faqshuman vaccinedukeinstitute https://dhvi.duke.edu/personnel/olivia-williams Olivia Williams | Duke Human Vaccine Institute olivia williamshuman vaccinedukeinstitute https://dhvi.duke.edu/programs-and-centers/duke-center-hiv-structural-biology/publications Publications | Duke Human Vaccine Institute Peer-reveiwed Papers Liu Q, Parsons RJ, Wiehe K, Edwards RJ, Saunders KO, Zhang P, Miao H, Tilahun K, Jones J, Chen Y, Hora B, Williams WB, Easterhoff D, Huang... human vaccinepublicationsdukeinstitute https://dhvi.duke.edu/about-us/training-and-mentoring-program/people/postdocs-and-other-associates Postdocs and Other Associates | Duke Human Vaccine Institute and otherhuman vaccinepostdocsassociatesduke https://dhvi.duke.edu/profile/christopher-wildrick-woods Christopher Wildrick Woods | Duke Human Vaccine Institute human vaccinechristopherwoodsdukeinstitute https://dhvi.duke.edu/programs-and-centers/duke-center-hiv-structural-biology/investigators Investigators | Duke Human Vaccine Institute human vaccineinvestigatorsdukeinstitute https://dhvi.duke.edu/programs-and-centers/immunology-virology-quality-assessment-center/research-programs/external Leadership at EQAPOL | Duke Human Vaccine Institute human vaccineleadershipdukeinstitute https://dhvi.duke.edu/publications Publications | Duke Human Vaccine Institute human vaccinepublicationsdukeinstitute https://dhvi.duke.edu/personnel/lori-hendrickson Lori Hendrickson | Duke Human Vaccine Institute human vaccinelorihendricksondukeinstitute https://dhvi.duke.edu/diseases/syphilis Syphilis | Duke Human Vaccine Institute Syphilis during pregnancy can result in miscarriage and fetal loss, or can result in congenital syphilis, an infection that causes organ damage and life-long... human vaccinesyphilisdukeinstitute https://dhvi.duke.edu/programs-and-centers/chavd/research-support-teams Research Support Teams | Duke Human Vaccine Institute The Duke CHAVD Scientific Research Support Units (SRSUs) form a well-coordinated translational pathway led by outstanding investigators that excel at... research support teamshuman vaccinedukeinstitute https://dhvi.duke.edu/programs-and-centers/chavd/news-and-events News | Duke Human Vaccine Institute human vaccinenewsdukeinstitute https://dhvi.duke.edu/about-us/giving Giving | Duke Human Vaccine Institute At the Duke Human Vaccine Institute, we believe in the extraordinary impact of generosity. human vaccinegivingdukeinstitute https://dhvi.duke.edu/personnel/damani-hillman-ccrp D'Amani Hillman, CCRP | Duke Human Vaccine Institute human vaccineamanihillmanccrpduke https://dhvi.duke.edu/personnel/raul-louzao Raul Louzao | Duke Human Vaccine Institute Mr. Louzao is the Scientific Manager of the Immunology and Virology Quality Assurance Laboratory (IVQAC) which serves as the EQAPOL Central Laboratory. For the... human vaccinerauldukeinstitute https://dhvi.duke.edu/personnel/garry-juhans Garry Juhans | Duke Human Vaccine Institute human vaccinegarrydukeinstitute https://dhvi.duke.edu/profile/herman-ford-staats Herman Ford Staats | Duke Human Vaccine Institute human vaccinehermanfordstaatsduke https://dhvi.duke.edu/profile/kent-james-weinhold Kent James Weinhold | Duke Human Vaccine Institute human vaccinekentjamesdukeinstitute https://dhvi.duke.edu/programs-and-centers/pandemic-preparedness/duke-infectious-disease-response-training-didrt-0 Resources and Links for Pandemic Preparedness Programs | Duke Human Vaccine Institute NIEHS National Clearinghouse for Worker Safety and Health Training NIEHS Worker Training Program CDC COVID-19 Page CDC Ebola Virus Page CDC Severe Acute... resources and linkspandemic preparednesshuman vaccine https://dhvi.duke.edu/profile/robert-joseph-rolfe Robert Joseph Rolfe | Duke Human Vaccine Institute human vaccinerobertjosephrolfeduke https://pubmed.ncbi.nlm.nih.gov/38854753/?dopt=Abstract Estimated Human Papillomavirus Vaccine Coverage Among Females 9-45 Years of Age - China, 2017-2022 This study presents evidence of low HPV vaccine coverage when administered outside of a national immunization program. Therefore, it is recommended that the... https://www.livescience.com/early-hiv-vaccine-trial-results.html HIV vaccine stimulates 'rare immune cells' in early human trials | Live Science Apr 7, 2021 - The vaccine stimulated a set of one-in-a-million immune cells. immune cells https://www.techtransfer.nih.gov/patent/e-122-1988-0-il-16 GENE FOR ENCODING A HUMAN MALARIA VACCINE ANTIGEN | Technology Transfer malaria vaccinegeneencodinghumanantigen https://pmc.ncbi.nlm.nih.gov/articles/PMC6361347/ Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women - PMC Over an 11-year period after HPV vaccine introduction, we found in this community-based surveillance study evidence of vaccine effectiveness and herd... human papillomavirus vaccineyoung womeneffectiveness https://www.mdpi.com/2076-393X/8/1/117 Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in... Vaccine safety surveillance is essential in vaccination programs. We accomplished a descriptive study of surveillance AEFI-reporting rate in human... human papillomavirus vaccineadverse events https://health.economictimes.indiatimes.com/news/industry/bangladeshs-1st-homegrown-covid-19-vaccine-gets-clearance-for-human-trials/92956734 Bangavax: Bangladesh's 1st homegrown COVID-19 vaccine gets clearance for human trials, ETHealthworld Bangavax: The vaccine can reportedly be stored at a temperature of 4 degrees Celsius for one month and of minus 20 degrees Celsius for up to six months. https://scholars.lib.ntu.edu.tw/entities/publication/998b65cc-a587-4edc-b9b8-a0b4f8bb923e Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants https://kidshealth.org/BarbaraBushChildrens/en/parents/hpv-vaccine.html Your Child's Vaccines: Human Papillomavirus (HPV) Vaccine (for Parents) - Barbara Bush Children's... Find out when and why your child needs to get this vaccine. human papillomavirus hpv https://economictimes.indiatimes.com/news/politics-and-nation/human-clinical-trials-for-covid-19-vaccine-initiated-in-india-icmr/articleshow/76964826.cms Human trials for COVID-19 vaccine initiated in India, with 1,000 volunteers: ICMR - The Economic... The Drugs Controller General of India (DCGI) has permitted two vaccines -- one developed by Bharat Biotech International Limited in collaboration with the... https://pubmed.ncbi.nlm.nih.gov/20179231/ An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and... Vaccination with mutationally inactivated, nononcogenic Ad-HER2-ki results in robust polyclonal immune responses to HER2 in tolerant models, which translates... https://pmc.ncbi.nlm.nih.gov/articles/PMC302470/ Protective Study with a Group A Streptococcal M Protein Vaccine. INFECTIVITY CHALLENGE OF HUMAN... Healthy adult male volunteers were immunized with purified M protein from Group A streptococci. Type 1. The vaccine was administered subcutaneously as an... https://www.jpost.com/health-science/singapore-scientists-to-start-covid-19-vaccine-human-trials-in-august-631648 Singapore scientists to start COVID-19 vaccine human trials in August | The Jerusalem Post More than 100 vaccines are being developed globally, including several already in human trials from the likes of AstraZeneca and Pfizer. https://researchconnect.buffalo.edu/en/publications/acceptability-of-the-human-papillomavirus-vaccine-among-diverse-h/ Acceptability of the human papillomavirus vaccine among diverse hispanic mothers and grandmothers -... human papillomavirus vaccineof the https://www.techtransfer.nih.gov/patent/e-297-2016-2-au-11 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES |... respiratory syncytial virusvaccine candidatesfor human